About the Journal

About Us

The International Journal of Drug and Medical Device Research (IJD-MDR) having e-ISSN: 3117-7557 published by The Scientific Institute of Stanford & Oxbridge Rowan Group (TSI–SORG) is a peer-reviewed, open-access international journal dedicated to advancing scientific knowledge and innovation in the fields of drug research, pharmaceutical sciences, and medical devices. Our principal mission is to provide a robust and respected forum for researchers, clinicians, engineers, and industry professionals worldwide to share original research, reviews, case studies, and technical innovations — thereby fostering cross-disciplinary collaboration and accelerating the translation of research into practice.

We strive to uphold the highest standards of academic integrity, transparency and scientific rigor. All submitted manuscripts undergo a thorough peer-review process managed by a qualified editorial board. On acceptance, articles are published online and made freely accessible, facilitating wide dissemination and ensuring that cutting-edge research is available to the global scientific community without barriers.


Aims & Scope

IJD-MDR welcomes original contributions, review articles, short communications, case reports, technical notes, and letters to the editor in — but not limited to — the following areas:

 Drug & Pharmaceutical Sciences

  • Drug discovery & development

  • Medicinal / pharmaceutical chemistry

  • Pharmacology and toxicology

  • Pharmacokinetics, pharmacodynamics, biopharmaceutics

  • Novel drug delivery systems (including nanomedicine, controlled release, targeted delivery)

  • Formulation development, quality control, stability studies

  • Preclinical research, in vitro and in vivo studies

  • Pharmacogenomics, molecular biology, computational chemistry / molecular modeling

Medical Devices & Biomedical Engineering

  • Design, development, and innovation of medical devices (diagnostic, therapeutic, monitoring, implantable devices, etc.)

  • Device validation, safety testing, regulatory compliance

  • Biomedical instrumentation, biomaterials, tissue-engineering devices

  • Clinical and preclinical evaluation of medical devices

  • Integration of medical devices with drug delivery (e.g. drug-device combinations, drug-eluting implants)

  • Regulatory science, medical device policies, quality assurance & standards

Clinical & Translational Research

  • Clinical trials and human studies involving drugs and/or devices

  • Pharmacovigilance, drug safety, adverse event reporting

  • Real-world evidence, pharmacoepidemiology, health outcomes research

  • Translating preclinical findings to clinical applications

  • Interdisciplinary research bridging pharmaceutical, medical, and engineering sciences

Reviews, Meta-analyses & Perspectives

  • Comprehensive reviews of current research and future trends

  • Meta-analyses and systematic reviews on drug therapies or device efficacy/safety

  • Commentaries, opinions, regulatory updates, policy analyses

  • Technical reports, white-papers, and guidelines relevant to drug and device development


Our Commitment

  • Quality & Integrity: We follow a rigorous peer-review process to ensure high scientific standards. All submissions must represent original work not published elsewhere.

  • Open Access: Published articles are freely available online under an open access model — ensuring maximum visibility and accessibility.

  • Global Collaboration: We welcome submissions from researchers, academicians, clinicians and industry professionals worldwide.

  • Interdisciplinary Approach: By bridging drug research, device development and clinical science, we aim to foster innovation that can translate into real-world health solutions.

Whether you are investigating a novel drug molecule, developing a next-generation medical device, or evaluating clinical outcomes — International Journal of Drug and Medical Device Research offers a comprehensive, credible, and accessible platform to share your work with the global scientific community.